Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
49 hedge funds and large institutions have $35.8M invested in Marrone Bio Innovations, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 7 reducing their positions, and 23 closing their positions.
257% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 7
22% less funds holding
Funds holding: 63 → 49 (-14)
61% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 23
67% less call options, than puts
Call options by funds: $2K | Put options by funds: $6K
81% less capital invested
Capital invested by funds: $191M → $35.8M (-$155M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$2.13M |
| 2 |
Primecap Management
Pasadena,
California
|
+$1.34M |
| 3 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
+$1.13M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.06M |
| 5 |
SM
Senvest Management
New York
|
+$906K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$11.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.21M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$6.87M |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$4.76M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$2.09M |
MBII Hedge Fund Activity: Q3 2014 in Review
49 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2014, worth a combined $35.8M — down 81% from $191M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of MBII and 9 opened new positions — a net loss of 14 holders — while 7 trimmed existing stakes and 25 added.
The largest buyer was Massachusetts Financial Services, adding an estimated $2.13M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $11.4M.
- 49 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2014, down from 63 in Q2 2014.
- Funds reported $35.8M of Marrone Bio Innovations, Inc. stock for Q3 2014, down 81% quarter-over-quarter.
- 9 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2014 and 23 closed out, a net change of -14 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q3 2014 was Massachusetts Financial Services, an estimated $2.13M added.
- The largest Marrone Bio Innovations, Inc. seller in Q3 2014 was Gilder Gagnon Howe & Co, an estimated $11.4M sold.
Based on aggregated 13F filings for Q3 2014.